-
June 14, 2013
UCB presented new data from the RAPID-PsA study and RAPID-axSpA study on Cimzia at the European League Against ...
-
June 14, 2013
The phase II study was voluntarily terminated due to the identification of abnormal liver biochemical tests during ...
-
June 10, 2013
The NDA on Gilead's sofosbuvir will be reviewed on a priority basis by the FDA.
-
May 22, 2013
Medtronic continues to suffer with weak core markets, but business seems to be getting slowly better and valuation ...
-
May 21, 2013
Roche has one of the best long-term growth profiles in the Big Pharma space
-
May 10, 2013
Dendreon looks increasingly irrelevant as the medical community moves on from Provenge.
-
May 08, 2013
Macro pressures are outweighing solid internal progress at Hologic.
-
May 03, 2013
Becton Dickinson is a great business, but investors seem to be too willing to overpay for today's relatively ...
-
April 29, 2013
Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
-
April 22, 2013
Kimberly-Clark's growth prospects make today's valuation hard to justify.
-
April 19, 2013
Uncertainty about procedure growth may be opening a window in these often-expensive shares
-
April 18, 2013
Although I do believe the long-term expectations for St. Jude are increasingly beatable, this could be a frustrating ...
-
April 17, 2013
Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
-
February 11, 2013
Domestic stock funds garnered a whopping $21 billion in the initial four weeks of 2013, according to Lipper. This ...
-
February 07, 2013
Idenix Pharmaceuticals, Inc. (IDIX) recently announced that the company has decided to discontinue its clinical ...
-
February 07, 2013
Elan Corporation (ELN) reported earnings of 15 cents per share for the fourth quarter of 2012 compared to the ...
-
February 06, 2013
Vertex Pharmaceuticals Inc. (VRTX) recently announced that the Health Service Executive (HSE) in the Republic of ...
-
February 06, 2013
Bayer's (BAYRY) Healthcare unit and Johnson & Johnson's (JNJ) Janssen Pharmaceuticals recently collaborated with ...
-
February 05, 2013
Yesterday, Liberty Property Trust (LRY) - a hybrid real estate investment trust (REIT) - unveiled its plan to ...
-
February 01, 2013
Perrigo Company's (PRGO) third quarter fiscal 2012 (ended March 31, 2012) adjusted earnings of $1.41 handsomely beat ...
